Sinotherapeutics Inc. (SHA:688247)
China · Delayed Price · Currency is CNY 7.95
-0.27 (-3.28%)
At close: Nov 13, 2026
Sinotherapeutics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 18.1 | 47.48 | 127.7 | 61.07 | 92.93 | 134.92 |
Depreciation & Amortization | 22.23 | 25.47 | 24.83 | 23.27 | 26.43 | 26.94 |
Other Amortization | 10.17 | 6.93 | 0.62 | 0.78 | 1.54 | 1.84 |
Loss (Gain) From Sale of Assets | - | - | - | -0.08 | -0.16 | 0.02 |
Asset Writedown & Restructuring Costs | 1.23 | 1.23 | 0.59 | 1.72 | -2.55 | 1.04 |
Loss (Gain) From Sale of Investments | -9.29 | -9.29 | -11 | -9.61 | -20.79 | -3.9 |
Stock-Based Compensation | - | - | - | - | - | 7.94 |
Provision & Write-off of Bad Debts | 1.35 | 1.35 | 3.66 | 0.81 | 1.43 | -0.29 |
Other Operating Activities | 58.81 | 18.71 | -3.42 | -1.22 | -5.31 | 4.25 |
Change in Accounts Receivable | 22.89 | 22.89 | -25.28 | -2.18 | -42.77 | -6.61 |
Change in Inventory | 14.43 | 14.43 | -16.46 | -56.47 | 13.83 | -0.05 |
Change in Accounts Payable | -17.75 | -17.75 | 17.53 | -4.11 | 12.6 | -52.23 |
Change in Other Net Operating Assets | -23.4 | -16.29 | 16.63 | -3.03 | -3.5 | 33.69 |
Operating Cash Flow | 106.04 | 95.33 | 130.23 | 12.96 | 73.18 | 145.77 |
Operating Cash Flow Growth | -11.51% | -26.80% | 905.01% | -82.29% | -49.80% | -30.60% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -26.21 | -41.56 | -94.93 | -38.96 | -176.34 | -16.01 |
Cash Acquisitions | - | - | - | - | -10.85 | - |
Investment in Securities | -232.5 | 148.9 | -399.89 | -84.41 | -20 | -52.6 |
Other Investing Activities | 8.9 | 9.64 | 10.98 | 15.79 | 6.88 | 4.38 |
Investing Cash Flow | -249.81 | 116.98 | -483.84 | -107.57 | -200.31 | -64.23 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -0.07 | -0.07 | -0.16 | -0.92 | -0.93 |
Lease Payments | -0.07 | -0.07 | -0.07 | -0.16 | -0.92 | -0.93 |
Net Debt Issued (Repaid) | -0.07 | -0.07 | -0.07 | -0.16 | -0.92 | -0.93 |
Issuance of Common Stock | - | - | - | - | 389.93 | - |
Repurchase of Common Stock | - | - | -36.15 | - | - | - |
Common Dividends Paid | -15.72 | -27.84 | -27.88 | -28.11 | - | - |
Other Financing Activities | 0.02 | - | - | - | -13.36 | - |
Financing Cash Flow | -15.77 | -27.91 | -64.09 | -28.27 | 375.65 | -0.93 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -5.79 | -3.29 | 1.71 | 1.52 | 2.97 | -2.9 |
Net Cash Flow | -165.32 | 181.1 | -416 | -121.36 | 251.5 | 77.71 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 79.83 | 53.77 | 35.3 | -26 | -103.15 | 129.77 |
Free Cash Flow Growth | 133.55% | 52.32% | - | - | - | -24.42% |
Free Cash Flow Margin | 20.07% | 12.04% | 6.90% | -8.67% | -41.67% | 41.13% |
Free Cash Flow Per Share | 0.19 | 0.13 | 0.08 | -0.06 | -0.24 | 0.32 |
Levered Free Cash Flow | 66.41 | 46.59 | -22.06 | -42.97 | -150.32 | 30.86 |
Unlevered Free Cash Flow | 66.41 | 46.59 | -22.06 | -42.95 | -150.18 | 31.01 |
Free Cash Flow After Leases | 79.76 | 53.7 | 35.23 | -26.16 | -104.07 | 128.83 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 8.63 | 20.01 | 5.13 | 1.28 | 9.17 | 1.1 |
Change in Working Capital | 3.45 | 3.45 | -12.76 | -63.78 | -20.34 | -26.98 |